| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Mesa Laboratories, Inc. (MLAB) have been net buyers, picking up 900 shares worth roughly $102K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 19.8K | $2.48M | - | |
| Dir | 19.4K | $2.44M | - | |
| Dir | 12.3K | $1.55M | - | |
| Dir | 9.1K | $1.14M | - | |
| Dir | 7.7K | $961.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2021 | John James Sullivan69 | Director | Sell | 1,250 | $280.82 | $351,025.00 | -2.0% | |
| Dec 11, 2020 | David M Kelly59 | Director | Sell | 250 | $283.18 | $70,795.00 | -9.6% | |
| Dec 1, 2020 | John James Sullivan69 | Director | Sell | 1,250 | $275.22 | $344,025.00 | -2.0% | |
| Nov 17, 2020 | John Sakys79 | CFO | Sale+OE | 984 | $290.00 | $285,360.00 | -22.7% | |
| Nov 16, 2020 | David M Kelly59 | Director | Sale+OE | 704 | $283.31 | $199,450.24 | -21.3% | |
| Nov 13, 2020 | Evan Guillemin68 | Director | Sale+OE | 2,050 | $274.30 | $562,315.00 | -5.4% | |
| Nov 12, 2020 | Evan Guillemin68 | Director | Sale+OE | 950 | $273.77 | $260,081.50 | -2.6% | |
| Nov 11, 2020 | John James Sullivan69 | Director | Sell | 1,250 | $272.36 | $340,450.00 | -2.0% | |
| Nov 9, 2020 | Brian David Archbold69 | SVP Continuous Improvement | Sale+OE | 533 | $272.11 | $145,034.63 | -69.7% | |
| Oct 8, 2020 | John Sakys79 | CFO | Sale+OE | 942 | $276.90 | $260,839.80 | -21.9% |